According to Kangtuo Medical's announcement, Xi'an Meiyan Angel Biotechnology Co., Ltd., a holding subsidiary of the company, recently obtained the third “Medical Device Registration Certificate” issued by the State Drug Administration. The product name is injectable cross-linked sodium hyaluronate gel, which is used to inject and fill the intradermal layer of the neck to correct severe horizontal lines on the neck. The registration certificate is valid until August 23, 2031. This approval marks that the company has made substantial progress in extending its strategy to the field of dermal fillers, which will enrich product categories, improve business layout, and enhance overall competitiveness in the consumer medicine field. The future performance of the product is affected by factors such as market expansion, and there is uncertainty about sales and profit contributions.

According to Kangtuo Medical's announcement, Xi'an Meiyan Angel Biotechnology Co., Ltd., a holding subsidiary of the company, recently obtained the third “Medical Device Registration Certificate” issued by the State Drug Administration. The product name is injectable cross-linked sodium hyaluronate gel, which is used to inject and fill the intradermal layer of the neck to correct severe horizontal lines on the neck. The registration certificate is valid until August 23, 2031. This approval marks that the company has made substantial progress in extending its strategy to the field of dermal fillers, which will enrich product categories, improve business layout, and enhance overall competitiveness in the consumer medicine field. The future performance of the product is affected by factors such as market expansion, and there is uncertainty about sales and profit contributions.